Follow
Reham Ajina
Reham Ajina
Assistant Professor, College of Applied Medical Sciences, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Verified email at ksau-hs.edu.sa
Title
Cited by
Cited by
Year
Advances in immunotherapy for glioblastoma multiforme
AB Mahmoud, R Ajina, S Aref, M Darwish, M Alsayb, M Taher, SA AlSharif, ...
Frontiers in Immunology, 6063, 2022
362022
T-cell immunity in pancreatic cancer
R Ajina, LM Weiner
Pancreas 49 (8), 1014-1023, 2020
262020
SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice
R Ajina, D Zamalin, A Zuo, M Moussa, M Catalfamo, SA Jablonski, ...
Oncoimmunology 8 (5), e1577127, 2019
192019
An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection
CW Shuptrine, R Ajina, EJ Fertig, SA Jablonski, HK Lyerly, ZC Hartman, ...
Cancer Immunology, Immunotherapy 66 (12), 1529-1544, 2017
142017
Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies
R Ajina, DJ Zahavi, YW Zhang, LM Weiner
Seminars in cancer biology 65, 28-37, 2020
132020
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ...
Journal for ImmunoTherapy of Cancer 4 (1), 107-221, 2016
122016
Antitumor T-cell Immunity Contributes to Pancreatic Cancer Immune Resistance
R Ajina, ZX Malchiodi, AA Fitzgerald, A Zuo, S Wang, M Moussa, ...
Cancer Immunology Research 9 (4), 386-400, 2021
112021
Functional genomics: paving the way for more successful cancer immunotherapy
R Ajina, D Zamalin, LM Weiner
Briefings in functional genomics 18 (2), 86-98, 2019
92019
SARS-CoV-2 RBD protein enhances the oncolytic activity of the vesicular stomatitis virus
AA Alkayyal, R Ajina, M Cacciabue, AA Alkayyal, NH Saeedi, TH Alshehry, ...
Frontiers in Immunology 14, 278, 0
4
Paediatric Asthma and the Microbiome: A Systematic Review
MG Aldriwesh, AM Al-Mutairi, AS Alharbi, HY Aljohani, NA Alzahrani, ...
Microorganisms 11 (4), 939, 2023
32023
Cancer Immunotherapy
R Ajina, D Aldeghaither, S Jablonski, LM Weiner
Elsevier, 2017
32017
Therapy with BXCL701 (B), a DPP8, DPP9, DPPIV and FAP inhibitor, in combination with anti-PD1 antibody (PD1) in a syngeneic murine pancreatic ductal adenocarcinoma (PDAC) model …
S Wang, A Fitzgerald, R Ajina, SA Jablonsk, LM Weiner, J MacDougall, ...
Cancer Research 80 (16 Supplement), 6636-6636, 2020
12020
Immune Selection Pressure Contributes to Pancreatic Cancer Immune Evasion
R Ajina, A Zuo, S Wang, M Moussa, CJ Cooper, Y Shen, QR Johnson, ...
bioRxiv, 2020
12020
Combination therapy with immune checkpoint inhibitor and CCK-receptor blockade increases survival of pancreatic cancer
JP Smith, S Wang, A Reham, SA Jablonski, LM Weiner
Cancer Research 76 (14 Supplement), 4023-4023, 2016
12016
Repurposing the oncolytic virus VSV∆ 51M as a COVID-19 vaccine
AA Alkayyal, MM Darwish, R Ajina, SY Alabbas, MA Alotaibi, ...
Frontiers in Bioengineering and Biotechnology 11, 1150892, 2023
2023
P-288 Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia
R Ajina, A Alhareeri, W Philip, N Alsekait, N Alarifi, H Alismail, ...
Annals of Oncology 34, S117, 2023
2023
Outcomes of molecular tumor board recommendations for cancer patients with progression on standard of care therapies in Saudi Arabia
K Alshammari, F Sabatin, M Hazar-Rethinam, F Alotaibi, R Ajina, ...
Cancer Research 83 (7_Supplement), 938-938, 2023
2023
Identifying Molecular Determinants of Immune Rejection in Pancreatic Cancer
RS Ajina
Georgetown University, 2020
2020
Selective induction of S100a8/a9 heterodimer protein in pancreatic cancer in response to immune selection pressure
L Weiner, R Ajina
JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019
2019
Malignant pancreatic cancer cells respond to immune selection pressure to foster immunosuppression
R Ajina, A Zuo, M Moussa, SJ Cooper, Y Shen, QR Johnson, JM Parks, ...
Cancer Research 79 (13 Supplement), 4584-4584, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20